ScreenerHero

ZIVOZIVO Bioscience, Inc.

NAS · US · Healthcare · Biotechnology · zivobioscience.com
4.250USD+4.94%Mkt Cap: 17.91M $P/E: —

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap17.91M $
Enterprise Value16.12M $
Revenue (TTM)209.03K $
Gross Profit48.95K $
Net Income (TTM)-13.38M $
Revenue/Share0.0560 USD
Last Price4.250 USD
Fiscal Year EndDec 2024
MR QuarterSep 2025
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS98978N2009
Valuation
P/E (Trailing)—
P/E (Forward)-3.29
PEG—
EV/EBITDA—
EV/Revenue77.13
P/S79.65
P/B-4.60
EPS (TTM)-2.18
EPS (Forward)-1.20
52W Range
1.11017% of range19.65
52W High19.65 USD
52W Low1.110 USD
Profitability
Gross Margin31.14%
Oper. Margin-1551.76%
EBITDA Margin0.00%
Profit Margin-8513.44%
ROE2599.52%
ROA-814.60%
Growth
Revenue Growth108.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.31M $
CapEx (TTM)—
FCF Margin-1252.12%
FCF Yield-14.61%
Net Debt762.47K $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.49
Current Ratio0.08
Quick Ratio0.02
Book Value/Sh-0.8580 USD
Cash/Share0.0150 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateOct 27, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.22M
Float1.47M
Insiders47.30%
Institutions0.10%
Short Interest
Short Ratio6.7d
Short % Float2.61%
Short % Out.2.04%
Shares Short35.47K
Short (prev mo.)12.81K
Technical
SMA 504.228 (+0.5%)
SMA 2006.751 (-37.0%)
Beta0.18
S&P 52W Chg18.16%
Avg Vol (30d)417
Avg Vol (10d)130
Technical Indicators
RSI (14)51.9
MACD0.0071
MACD Signal0.0121
MACD Hist.-0.0050
BB Upper4.822 USD
BB Middle4.196 USD
BB Lower3.570 USD
BB Width29.86%
ATR (14)0.3160 USD
Vol Ratio (20d)0.26x